Company news

Ondine Biomedical, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

LANTERN Safety Results Presented at IDWeek

October 28, 2026

Holding(s) in Company

October 26, 2026

Ottawa Heart Institute Reduces CABG SSIs by 51.5%

October 23, 2026

Capital Access Window - Ondine Biomedical Inc

October 20, 2026

Result of Fundraise, Restoration of Trading & TVR

October 20, 2026

Proposed c.£10m (C$18.88m) Fundraise

October 19, 2026

Capital Access Window - Ondine Biomedical Inc.

September 30, 2026

Capital Access Window

September 30, 2026

2026 Interim Results & Post-Period Momentum

September 30, 2026

Ondine and Mela Advance NHS ICU Market Access

September 29, 2026

Steriwave Deploys in 5 Southern Ontario Hospitals

September 23, 2026

Investor Presentation of Phase 3 Topline Results

September 10, 2026

Largest Private Mexican Network Pilots Steriwave

September 7, 2026

Notification of major holdings

September 4, 2026

Positive Topline Results in US Phase 3 Study

September 1, 2026

Major Scottish Hospital Adopts Steriwave

July 30, 2026

Keynote Address at 8th Annual Photodynamic Day

July 1, 2026

Leeds drops SSI 78% over Mupirocin with Steriwave

June 30, 2026

Update on US Phase 3 Pivotal Study

June 22, 2026

Leeds Drops SSIs by 78.5% in Complex Brain Surgery

June 18, 2026

Grant of Options and RSUs, and Issue of Warrants

June 8, 2026

2025 Full Year Results and Annual Report

June 4, 2026

Steriwave ICU Study Outcomes Presented at CSRT2026

May 26, 2026

Notification of major holdings - hInsight-NX, LLC

May 6, 2026

Ondine Presented Steriwave Data at IPC 2026

April 30, 2026

Proposed c.£5 million (C$9.23 million) Fundraise

April 28, 2026

ICU Study to be Presented at 2026 CACCN Conference

April 27, 2026

Marked Reduction in SSIs at Ottawa Heart Institute

April 23, 2026

Two Abstracts Accepted at World Congress

April 22, 2026

Steriwave ICU Study Shows 39.5% Pneumonia Drop

April 14, 2026

Business Update

April 13, 2026

ICU Study Accepted for Publication

April 8, 2026

Holdings in Company

March 24, 2026

Ondine Provides Update on US Phase 3 Pivotal Study

March 10, 2026

Share Issuance for ICU Study Submission

February 25, 2026

Holding(s) in Company

February 20, 2026

Ondine and Mid Yorks Win National Award

February 6, 2026

Steriwave Up for 2025 “Product of the Year” Award

February 2, 2026

Expanding Steriwave Use Across Vancouver Island

January 27, 2026

Steriwave Expands into ENT Surgery in Spain

January 22, 2026

New Independent Study Supports Photodisinfection

January 13, 2026

Finalist for 2nd National Award for SSI reduction

December 23, 2025

First German Hospital Pilots Steriwave

December 22, 2025

Ondine shortlisted for HSJ Partnership Award

December 16, 2025

Topline Results Significant in Steriwave ICU Study

October 27, 2025

Cambridge’s Papworth Hospital Pilots Steriwave

October 2, 2025

Ondine Biomedical Continues Growth in H1 2025

September 26, 2025

Steriwave Now Protecting Patients with Cancer

September 23, 2025

Notice of Interim Results & Investor Presentation

September 19, 2025

Ondine Presents Major Economic Benefits at ICPIC

September 18, 2025

Older news releases →

Calls

The 5 newest of 9 calls. Every call is listed under its year.